Stay updated on Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial

Sign up to get notified when there's something new on the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry v3.5.3, and the previous revision v3.5.2 is no longer listed. This records a minor update to the revision history.
    Difference
    0.1%
    Check dated 2026-04-30T15:37:50.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T09:57:02.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Added revision v3.5.0 and removed revision v3.4.3 from the study record history.
    Difference
    0.1%
    Check dated 2026-03-25T20:49:58.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2026-03-18T14:44:41.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    New revision entry v3.4.3 added to the history and the previous v3.4.2 entry removed.
    Difference
    0.1%
    Check dated 2026-03-11T16:44:20.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 to the history and removed the funding-status notice and Revision: v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2026-02-11T01:47:13.000Z thumbnail image

Stay in the know with updates to Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tiragolumab Combo in PD-L1+ Cervical Cancer Clinical Trial page.